Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-21.80	64.21	82.10
Graham Fair Price	49.99	12.28	8.19
PEG	-32.93	0.81	-1.20
Price/Book	-45.79	183.02	337.64
Price/Cash Flow	-21.25	71.63	90.97
Prices/Earnings	-26.48	23.13	31.46
Price/Sales	-9.74	9.15	10.13
Price/FCF	-21.25	71.63	90.97
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.51	0.32	0.33
Operating Margin	17.10	0.14	0.12
ROA	24.15	0.05	0.04
ROE	2.68	1.98	-26.27
ROIC	0.07	0.09	26.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.06	-61.13
Dividends QOQ	< 0.005	0.07	31622.37
EBIT QOQ	-0.23	0.23	-3.30
EPS QOQ	-0.26	0.29	9.62
FCF QOQ	0.09	0.20	128.40
Revenue QOQ	-0.08	0.05	-39.49
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	81.10	81.77	0.83
Days Sales Outstanding (DSO)	8.61	10.14	17.82
Inventory Turnover	1.11	1.10	-0.82
Debt/Capitalization	0.98	0.96	-1.88
Quick Ratio	0.32	0.34	6.71
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.05	1.84	74.68
Cash	3.79	4.31	13.63
Capex	-0.87	-0.86	1.08
Free Cash Flow	3.91	4.70	20.24
Revenue	35.10	36.82	4.90
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.35	1.34	-0.98
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.93	7.90	-20.40
Naive Interpretation	Member

06 - Financial Health · Weak

Rating